Efficacy and safety of SBRT combined with sintilimab and IBI305 in patients with advanced HCC and previously failed immunotherapy: study protocol of a phase 2 clinical trial
Article in BMJ Open (June 2024)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Article in BMJ Open (June 2024)
Article in Journal of Clinical Medicine (December 2023)
Article in Journal of Clinical Medicine- Hue Central Hospital (August 2023)